Last reviewed · How we verify
XOPH5 Ointment
At a glance
| Generic name | XOPH5 Ointment |
|---|---|
| Sponsor | Topokine Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- XOPH5 Ointment CI brief — competitive landscape report
- XOPH5 Ointment updates RSS · CI watch RSS
- Topokine Therapeutics, Inc. portfolio CI